4.4 Article

MRI measurement of alanine uptake in a mouse xenograft model of U-87 MG glioblastoma

Journal

MAGNETIC RESONANCE IMAGING
Volume 93, Issue -, Pages 189-194

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.mri.2022.08.015

Keywords

MRI; Alanine; cancer metabolism; ASCT2; Amino acid contrast agent; Amino acid transporter

Funding

  1. Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2019 R1I1A1A01064082]

Ask authors/readers for more resources

This study investigated the potential use of alanine as an MRI contrast agent and measured its relaxation properties in solution. The uptake of alanine in a mouse xenograft model of glioblastoma was measured using MRI and compared with immunohistochemistry staining. Statistically significant differences in ASCT2 distribution were found between regions with strong and weak alanine uptake in MRI.
The potential use of alanine as an MRI contrast agent was investigated. The relaxation properties of alanine solutions were measured at 9.4 T. The T-2 relaxivity caused by the chemical exchange (R-2ex) between amine protons and water protons was 0.10 mM(-1) s(2) at 37 ?. As a demonstration, alanine uptake in a mouse xenograft model of U-87 MG glioblastoma was measured using MRI, and was compared with immunohistochemistry staining of ASCT2, a transporter that imports amino acids into cancer cells. Statistically significant (p = 0.0079) differences in ASCT2 distribution were found between regions that show strong and weak alanine uptake in MRI. To better understand the influence of perfusion, the effect of ASCT2 inhibition on the alanine uptake in MRI was investigated, and dynamic contrast enhanced MRI was compared with alanine MRI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available